Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback